Review of Pharmacological Strategies with Repurposed Drugs for Hereditary Hemorrhagic Telangiectasia Related Bleeding

The diagnosis of hereditary hemorrhagic telangiectasia (HHT) is based on the Curaçao criteria: epistaxis, telangiectases, arteriovenous malformations in internal organs, and family history. Genetically speaking, more than 90% of HHT patients show mutations in <i>ENG</i> or <i>ACVRL...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Virginia Albiñana, Angel M Cuesta, Isabel de Rojas-P, Eunate Gallardo-Vara, Lucía Recio-Poveda, Carmelo Bernabéu, Luisa María Botella
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MDPI AG 2020-06-01
Sarja:Journal of Clinical Medicine
Aiheet:
HHT
ALK1
endoglin
raloxifene
bazedoxifene
tranexamic acid
Linkit:https://www.mdpi.com/2077-0383/9/6/1766
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia